Aiwu Yang - Search Results

Year	Number of Results
2014	1
2017	1
2019	1
2020	1
2022	4
2023	4
2024	2

1

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, Hu ZT, Chai XQ, Peng R, Yang X, Gao C, Gao J, Wang SW, Zheng YM, Tang Z, Gao Q, Zhou J, Fan JB, Ke AW, Fan J. Wei CY, et al. J Hepatol. 2022 Jul;77(1):163-176. doi: 10.1016/j.jhep.2022.02.019. Epub 2022 Feb 24. J Hepatol. 2022. PMID: 35219791 Free article.

2

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Dong ZR, Cai JB, Shi GM, Yang YF, Huang XY, Zhang C, Dong RZ, Wei CY, Li T, Ke AW, Fan J. Dong ZR, et al. Cancer Lett. 2023 Jun 28;564:216186. doi: 10.1016/j.canlet.2023.216186. Epub 2023 Apr 25. Cancer Lett. 2023. PMID: 37105392

3

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.

Meng XL, Lu JC, Zeng HY, Chen Z, Guo XJ, Gao C, Pei YZ, Hu SY, Ye M, Sun QM, Yang GH, Cai JB, Huang PX, Yv L, Zhang L, Shi YH, Ke AW, Zhou J, Fan J, Chen Y, Huang XY, Shi GM. Meng XL, et al. Hepatol Int. 2023 Feb;17(1):63-76. doi: 10.1007/s12072-022-10445-1. Epub 2022 Nov 22. Hepatol Int. 2023. PMID: 36418844 Free PMC article.

4

Corrigendum to: "PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma" [J Hepatol 77 (2022) 163-176].

Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, Hu ZT, Chai XQ, Peng R, Yang X, Gao C, Gao J, Wang SW, Zheng YM, Tang Z, Gao Q, Zhou J, Cai JB, Ke AW, Fan J. Wei CY, et al. J Hepatol. 2023 Apr;78(4):881-882. doi: 10.1016/j.jhep.2022.11.004. Epub 2022 Dec 21. J Hepatol. 2023. PMID: 36564318 No abstract available.

5

Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway.

Huang Y, Wang S, Zhang X, Yang C, Wang S, Cheng H, Ke A, Gao C, Guo K. Huang Y, et al. Pharmacol Res. 2024 Feb;200:107082. doi: 10.1016/j.phrs.2024.107082. Epub 2024 Jan 26. Pharmacol Res. 2024. PMID: 38280440 Free article.

6

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Huang XY, Zhang PF, Wei CY, Peng R, Lu JC, Gao C, Cai JB, Yang X, Fan J, Ke AW, Zhou J, Shi GM. Huang XY, et al. Mol Cancer. 2020 May 19;19(1):92. doi: 10.1186/s12943-020-01213-6. Mol Cancer. 2020. PMID: 32430013 Free PMC article.

7

Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension.

Sun X, Yao K, Liu Q, Zhang H, Xing X, Fang A, Duan X, Yu M, Chen MY, Yang J, Goodkin ML. Sun X, et al. Ophthalmol Ther. 2023 Feb;12(1):341-353. doi: 10.1007/s40123-022-00593-w. Epub 2022 Nov 12. Ophthalmol Ther. 2023. PMID: 36370233 Free PMC article.

8

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.

Xie N, Cai JB, Zhang L, Zhang PF, Shen YH, Yang X, Lu JC, Gao DM, Kang Q, Liu LX, Zhang C, Huang XY, Zou H, Zhang XY, Song ZJ, Sun HX, Fu BM, Ke AW, Shi GM. Xie N, et al. Cell Death Dis. 2017 Dec 13;8(12):3205. doi: 10.1038/s41419-017-0015-6. Cell Death Dis. 2017. PMID: 29235470 Free PMC article.

9

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.

Peng R, Zhang PF, Yang X, Wei CY, Huang XY, Cai JB, Lu JC, Gao C, Sun HX, Gao Q, Bai DS, Shi GM, Ke AW, Fan J. Peng R, et al. J Exp Clin Cancer Res. 2019 Mar 5;38(1):113. doi: 10.1186/s13046-019-1113-3. J Exp Clin Cancer Res. 2019. PMID: 30836988 Free PMC article.

10

Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Huang XY, Zhang PF, Wei CY, Peng R, Lu JC, Gao C, Cai JB, Yang X, Fan J, Ke AW, Zhou J, Shi GM. Huang XY, et al. Mol Cancer. 2024 Feb 29;23(1):44. doi: 10.1186/s12943-024-01969-1. Mol Cancer. 2024. PMID: 38424621 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year